首页> 外国专利> Competitor's golden 1 and use of modified alpha

Competitor's golden 1 and use of modified alpha

机译:竞争对手的黄金1和修改后的alpha的使用

摘要

Revealing and publishing competitors as reference uses gold-1 to suppress signals between T cells and a second unit, for example. Limit antigen cells. Suppression of this disease is useful in the treatment of a variety of diseases, including autoimmune diseases, as well as grafts and hosts.It is also disclosed as a reference and use of gold-1 antagonists to inhibit the secretion of IFN-gamma by lymphocytes or other alpha___ alpha_ kappa_uuuuuuuuuuuuuu In mammals. Inhibition of IFN- gamma is useful for the treatment of inflammatory diseases or diseases such as inflammatory bowel disease.
机译:揭露和发布竞争对手作为参考,例如使用gold-1抑制T细胞和第二个单元之间的信号。限制抗原细胞。抑制这种疾病可用于治疗多种疾病,包括自身免疫性疾病以及移植物和宿主。它还被公开作为参考和使用gold-1拮抗剂抑制淋巴细胞分泌IFN-γ或其他alpha___ alpha_ kappa_uuuuuuuuuuuuuuu在哺乳动物中。 IFN-γ的抑制可用于治疗炎性疾病或诸如炎性肠病的疾病。

著录项

  • 公开/公告号CY1108480T1

    专利类型

  • 公开/公告日2014-04-09

    原文格式PDF

  • 申请/专利权人 BIOGEN IDEC MA INC.;

    申请/专利号CY200811001250T

  • 发明设计人 RENNERT PAUL D;

    申请日2008-11-03

  • 分类号A61K39/395;A61K38;A61K38/17;A61K39;A61K47/48;A61K49;A61P37/06;C07K14/705;C07K16/28;C07K17;C07K19;

  • 国家 CY

  • 入库时间 2022-08-21 15:58:24

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号